Compare OC & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OC | BIO |
|---|---|---|
| Founded | 1938 | 1952 |
| Country | United States | United States |
| Employees | N/A | 7450 |
| Industry | Industrial Machinery/Components | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 6.9B |
| IPO Year | 2006 | N/A |
| Metric | OC | BIO |
|---|---|---|
| Price | $108.33 | $281.09 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 4 |
| Target Price | $145.27 | ★ $339.75 |
| AVG Volume (30 Days) | ★ 1.0M | 380.5K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.61% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $2.74 |
| Revenue Next Year | $3.72 | $3.20 |
| P/E Ratio | ★ N/A | $9.72 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $97.53 | $211.43 |
| 52 Week High | $159.42 | $343.12 |
| Indicator | OC | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 34.35 | 58.14 |
| Support Level | $103.31 | $253.20 |
| Resistance Level | $110.63 | $288.48 |
| Average True Range (ATR) | 4.58 | 9.74 |
| MACD | -1.72 | 2.05 |
| Stochastic Oscillator | 7.86 | 91.48 |
Owens-Corning Inc is a building products company that offers roofing products and systems, insulation products (hermal and acoustical batts, loose fill insulation, spray foam insulation, wet use chopped strand, etc.), and doors and door systems. The company's reportable segments are: Roofing, Insulation, and Doors. Maximum revenue is generated from the Roofing segment, which manufactures and sells residential roofing shingles, oxidized asphalt materials, roofing components, and composite lumber mainly used in residential construction. This segment also manufactures and sells glass mat and specialty veil materials used in building and construction applications. Geographically, the company generates maximum revenue from the United States, followed by Europe, Asia-Pacific, and other markets.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.